Ginsenoside-Rg5 suppresses cyclin E-dependent protein kinase activity via up-regulating p21(Cip/WAF1) and down-regulating cyclin E in SK-HEP-1 cells

Anticancer Research

Volumn 17, Issue 2 A, 1997, Pages 1067-1072

  Lee, Kwang Youl ^a   Lee, You Hui ^b   Kim, Shin Il ^b   Park, Jeong Hill ^a   Lee, Seung Ki ^a  

^a Seoul National University   (South Korea)

^b Korea Ginseng Corporation   (South Korea)

Author keywords

Cyclin E dependent kinase; Ginsenoside Rg5; p21(Cip WAF1); SK HEP 1 cells

Indexed keywords

CYCLIN E; GINSENOSIDE; GINSENOSIDE RG5; PROTEIN KINASE; PROTEIN P21; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; ENZYME INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0030942927     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Baek NI, Kim DS, Lee YH, Park JD, Lee CB, Kim SI: Cytotoxicities of ginseng saponins and their degradation products against some cancer cell lines. Arch Pharm Res 18: 164-168, 1995.
2. Kitagawa I, Yoshikawa M, Yoshihara M, Hayashi T, Toniyama T: Chemical Studies on crude drug precession. I. On the constituents of Ginseng Radix Ruba. Yakugaku Zasshi 103: 612-622, 1983.
3. Ota T, Fujikawa-Yamamoto K, Zong Z-P, Yamazaki M, Odashima S: Plant-Glycoside Modulation of Cell Surface Related to Control of Differentiation cultures B16 melanoma cells. Cancer Res 47: 3863-3867, 1987.
4. Ota T, Meada M, Odashima S J: Mechanism of Action of Ginsenoside Rh2 : Uptake and Metabolism of Ginsenoside Rh2 by cultured B16 melanoma cells. J Pharm Sci 80: 1141-1146, 1991.
5. Odashima S, Ohta T, Kohno H: Control of phenotypic expression of cultured B16 melanoma cells by plant glycosides. Cancer Res 45: 2781-2784, 1985.
6. Fujikawa-Yamamoto K. Ota T, Odashima S, Abe H, Arichi S: Different responses in the cell cycle of tumor cells to ginsenoside Rh2. Cancer J 1: 349-352, 1987.
7. Hunter T, Pines J; Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 79: 573-582, 1994.
8. Pines J: Cyclins and cyclin-dependent kinases : a biochemical view. Biochem J 308: 697-711, 1995.
9. Nigg EA: Cyclin-dependent protein kinases; key regulators of the eukaryotic cell cycle. BioEssays 17: 471-480, 1995.
10. Morgan DO: Principles of CDK regulation. Nature 374: 131-134, 1995.
11. Sebastein B, Kakizuka A, Hunter T: Cdc25 activation of cyclin-dependent kinase by dephosphorylation of threonine-14 and tyrosine-15. Proc. Natl. Acad. Sci. USA 90: 3521-3524, 1993.
12. Hoffmann I, Draetta G, Karsenti E: Activation of the phosphatase activity of human CDC25A by CDK2-cyclin E dependent phosphorylation at the G1/S transition. EMBO J 13:4302-4310, 1994.
13. Dulic V, Lees E, Reed SI: Association of human cyclin E with a periodic G1-S phase protein kinase. Science 257:1958-1961, 1992.
14. Koff A, Giordano A, Desai D, Yamashita K, Harper W, Elledge S, Nishimoto T, Morgan DO, Franza R, Roberts J: Formation and activation of cyclin E-CDK2 complex during the G1 phase of the human cell cycle. Science 257: 1689-1693, 1992.
15. Koff A, Ohtsuki M, Polyak K, Roberts JM, Massague J: Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinases by TGF-beta. Science 260: 1689-1694, 1993.
16. Kip1) of cyclindependent kinase 4 activation. Cell 79: 487-496, 1994.
17. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev 8: 922, 1994.
18. El-Diery DW, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825, 1993.
19. Gu Y, Truck CW, Morgan DO: Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366: 707-710, 1993.
20. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D: p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704, 1993.
21. Dulic V, Drullinger LF, Lees E, Reed SI, Stein GH: Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-CDK2 and cyclin D1-CDK2 complexes. Proc Natl Acad Sci USA 90: 11034-11038, 1993.
22. Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM, Pagano M: Human cyclin E, a nuclear protein essential for the G1 to S phase transition. Mol Cell Biol 15: 2612-2624, 1995.
23. Fisher RP, Morgan DO: A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase. Cell 78: 713-724, 1994.
24. Gu Y, Rosenblatt J, Morgan DO: Cell cycle regulation of CDK2 activity by phosphorylation of Thr 160 and Tyr 15. EMBO J 11: 3995-4005, 1992.
25. Makela TP, Tassan JP, Nigg EA, Frutiger S, Hughes GJ, Weinberg RA: A cyclin associated with CDK-activating kinase MO15. Nature 371: 254-257, 1994.